The Legal Intelligencer By Shannon P. Duffy In two appeals that could have a huge impact on the litigation of drug product liability cases, the
So Far, Victories Are Few as Breast Cancer Patients Sue Wyeth Over Hormone Therapy
Journal of National Cancer Institute By: Renee Twombly There is no question that use of combination hormone therapy is associated with an increased risk of
Overturned $3M Verdict Explained in Hormone Replacement Therapy Opinion
Gina Passarella The Legal Intelligencer A woman who sued Wyeth, claiming her breast cancer was caused by the company’s hormone replacement drug, did not show
FDA’s Advisor’s Conclude “FDA’s Flaws Put Lives at Risk”
THE REPORT: COMPLETE REPORT (PDF): http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4329b_02_00_index.htmlhttp://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4329b_02_01_FDA%20Report%20on%20Science%20and%20Technology.pdf
